Biomarkers And Methods For Progression Prediction For Chronic Kidney Disease


Subject of the present invention are biomarkers and methods for the identification of an increased risk of the progression of chronic kidney disease (CKD), or for monitoring chronic kidney disease therapy, comprising the detecting the level of one or more of NTpro BNP, EGF, Apo H, GDF-15, and albumin-to-creatinine ratio.

Download PDF
Document Preview
Document History
  • Publication: May 7, 2015
  • Application: Oct 31, 2014
    WO EP 2014073413 W
  • Priority: Nov 4, 2013
    EP EP 13191345 A

Download Citation

Sign in to the Lens